Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

V Fossati

Showing results (11-20 of 36) with videos related to

Pageof 4
Sort By:
Leukemia & Lymphoma|January 1, 1992
Use of high-dose cytarabine in autologous bone marrow transplantation in acute myeloid leukemiaR Mozzana, A Della Volpe, C Butti, et al.
Oncology Reports|May 25, 2011
A clinical-study of immunotherapy versus endocrine therapy versus chemotherapy in the treatment of advanced pancreatic adenocarcinomaP Lissoni, A Ardizzoia, S Meregalli, et al.
Tumori|June 30, 1993
Radioendocrine therapy of brain tumors with the long acting opioid antagonist naltrexone in association with radiotherapyP Lissoni, S Meregalli, V Fossati, et al.
Tumori|December 31, 1994
A randomized study of immunotherapy with low-dose subcutaneous interleukin-2 plus melatonin vs chemotherapy with cisplatin and etoposide as first-line therapy for advanced non-small cell lung cancerP Lissoni, S Meregalli, V Fossati, et al.
Oncology|January 1, 1996
Increased survival time in brain glioblastomas by a radioneuroendocrine strategy with radiotherapy plus melatonin compared to radiotherapy aloneP Lissoni, S Meregalli, L Nosetto, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|May 1, 1995
A randomized study of neuroimmunotherapy with low-dose subcutaneous interleukin-2 plus melatonin compared to supportive care alone in patients with untreatable metastatic solid tumourP Lissoni, S Barni, V Fossati, et al.
British Journal of Cancer|April 1, 1995
Modulation of cancer endocrine therapy by melatonin: a phase II study of tamoxifen plus melatonin in metastatic breast cancer patients progressing under tamoxifen aloneP Lissoni, S Barni, S Meregalli, et al.
Tumori|February 28, 1993
Concurrent carboplatin (CBDCA), vindesine (VDS) and radiotherapy in stage III non small cell lung cancer (NSCLC)M Tomirotti, G Gramegna, P Mantellini, et al.
La Radiologia Medica|October 1, 1990
[Technical-dosimetric aspects of a simplified procedure for intraoperative radiotherapy with electrons. Experience at the San Raffaele Hospital of Milan]G M Cattaneo, V Fossati, R Calandrino, et al.
Tumori|August 31, 1993
Immunoendocrine therapy with interleukin-2 (IL-2) and medroxyprogesterone acetate (MPA): a randomized study with or without MPA in metastatic renal cancer patients during IL-2 maintenance treatment after response or stable disease to IL-2 subcutaneous therapyP Lissoni, S Barni, G Tancini, et al.
Pageof 4

Showing results (11-20 of 36) with videos related to

Sort By:
Pageof 4
Leukemia & Lymphoma|January 1, 1992
Use of high-dose cytarabine in autologous bone marrow transplantation in acute myeloid leukemiaR Mozzana, A Della Volpe, C Butti, et al.
Oncology Reports|May 25, 2011
A clinical-study of immunotherapy versus endocrine therapy versus chemotherapy in the treatment of advanced pancreatic adenocarcinomaP Lissoni, A Ardizzoia, S Meregalli, et al.
Tumori|June 30, 1993
Radioendocrine therapy of brain tumors with the long acting opioid antagonist naltrexone in association with radiotherapyP Lissoni, S Meregalli, V Fossati, et al.
Tumori|December 31, 1994
A randomized study of immunotherapy with low-dose subcutaneous interleukin-2 plus melatonin vs chemotherapy with cisplatin and etoposide as first-line therapy for advanced non-small cell lung cancerP Lissoni, S Meregalli, V Fossati, et al.
Oncology|January 1, 1996
Increased survival time in brain glioblastomas by a radioneuroendocrine strategy with radiotherapy plus melatonin compared to radiotherapy aloneP Lissoni, S Meregalli, L Nosetto, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|May 1, 1995
A randomized study of neuroimmunotherapy with low-dose subcutaneous interleukin-2 plus melatonin compared to supportive care alone in patients with untreatable metastatic solid tumourP Lissoni, S Barni, V Fossati, et al.
British Journal of Cancer|April 1, 1995
Modulation of cancer endocrine therapy by melatonin: a phase II study of tamoxifen plus melatonin in metastatic breast cancer patients progressing under tamoxifen aloneP Lissoni, S Barni, S Meregalli, et al.
Tumori|February 28, 1993
Concurrent carboplatin (CBDCA), vindesine (VDS) and radiotherapy in stage III non small cell lung cancer (NSCLC)M Tomirotti, G Gramegna, P Mantellini, et al.
La Radiologia Medica|October 1, 1990
[Technical-dosimetric aspects of a simplified procedure for intraoperative radiotherapy with electrons. Experience at the San Raffaele Hospital of Milan]G M Cattaneo, V Fossati, R Calandrino, et al.
Tumori|August 31, 1993
Immunoendocrine therapy with interleukin-2 (IL-2) and medroxyprogesterone acetate (MPA): a randomized study with or without MPA in metastatic renal cancer patients during IL-2 maintenance treatment after response or stable disease to IL-2 subcutaneous therapyP Lissoni, S Barni, G Tancini, et al.
Pageof 4